We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCS
1726
DELISTED
Steelcase
SCS
| $1.65M | ﹤0.01% |
107,130
-3,810
| -3% | -$52.2K |
|
1727
Anika Therapeutics
ANIK
$258M
| $1.64M | ﹤0.01% |
28,345
+625
| +2% | +$32.7K |
|
1728
Kearny Financial
KRNY
$604M
| $1.64M | ﹤0.01% |
107,024
+510
| +0.5% | +$7.43K |
|
1729
LGI Homes
LGIH
$1.27B
| $1.64M | ﹤0.01% |
33,813
+960
| +3% | +$42.7K |
|
1730
Pilgrim's Pride
PPC
$6.51B
| $1.64M | ﹤0.01% |
57,726
-1,303
| -2% | -$34.3K |
|
1731
Quanex
NX
$819M
| $1.64M | ﹤0.01% |
71,379
+1,325
| +2% | +$27.4K |
|
|
HT
1732
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.64M | ﹤0.01% |
87,637
+1,732
| +2% | +$31.8K |
|
|
AYR
1733
DELISTED
Aircastle Ltd
AYR
| $1.63M | ﹤0.01% |
73,161
+330
| +0.5% | +$7.34K |
|
|
HTZ
1734
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.63M | ﹤0.01% |
83,825
+2,627
| +3% | +$41.4K |
|
1735
Dine Brands
DIN
$456M
| $1.63M | ﹤0.01% |
37,855
+1,945
| +5% | +$79.5K |
|
|
BFS
1736
Saul Centers
BFS
$836M
| $1.63M | ﹤0.01% |
26,242
+188
| +0.7% | +$11.3K |
|
|
AEGN
1737
DELISTED
Aegion Corp
AEGN
| $1.62M | ﹤0.01% |
69,399
+97
| +0.1% | +$2.14K |
|
1738
Helios Technologies
HLIO
$2.57B
| $1.61M | ﹤0.01% |
29,903
+310
| +1% | +$14.4K |
|
|
INFN
1739
DELISTED
Infinera Corporation Common Stock
INFN
| $1.61M | ﹤0.01% |
181,093
+1,010
| +0.6% | +$9.72K |
|
1740
Green Plains
GPRE
$1.18B
| $1.6M | ﹤0.01% |
79,666
+2,572
| +3% | +$49.1K |
|
1741
Ubiquiti
UI
$33.7B
| $1.6M | ﹤0.01% |
28,589
+2,350
| +9% | +$135K |
|
|
CYS
1742
DELISTED
CYS Investments Inc.
CYS
| $1.6M | ﹤0.01% |
185,239
+2,665
| +1% | +$23K |
|
1743
John B. Sanfilippo & Son
JBSS
$967M
| $1.6M | ﹤0.01% |
23,736
+7,530
| +46% | +$483K |
|
1744
Artisan Partners
APAM
$2.79B
| $1.6M | ﹤0.01% |
48,981
+735
| +2% | +$22.8K |
|
1745
Trade Desk
TTD
$8.48B
| $1.59M | ﹤0.01% |
259,080
+68,790
| +36% | +$372K |
|
1746
First Busey Corp
BUSE
$2.57B
| $1.59M | ﹤0.01% |
50,674
+6,364
| +14% | +$186K |
|
1747
Manitowoc
MTW
$497M
| $1.59M | ﹤0.01% |
44,113
+223
| +0.5% | +$6.48K |
|
|
RWT
1748
Redwood Trust
RWT
$574M
| $1.59M | ﹤0.01% |
97,355
+1,344
| +1% | +$22.5K |
|
1749
Theravance Biopharma
TBPH
$874M
| $1.59M | ﹤0.01% |
46,318
+675
| +1% | +$22.1K |
|
1750
Kelly Services Class A
KELYA
$514M
| $1.58M | ﹤0.01% |
62,828
+2,104
| +3% | +$47.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.